Trotter; B. Wesley
Patent Applications and Registrations
Patent applications and USPTO patent grants for Trotter; B. Wesley.The latest application filed is for "substituted indazole compounds as rorgammat inhibitors and uses thereof".
Company Profile
5.35.39
- Trotter; B. Wesley - Medfield MA
- Trotter; B. Wesley - Glenside PA
- Trotter; B. Wesley - Newton Highlands MA US
- TROTTER; B. Wesley - Boston MA US
- Trotter; B. Wesley - Newton Highland MA US
Patent Activity
| Patent | Date |
|---|---|
| Substituted indazole compounds as RORgammaT inhibitors and uses thereof Grant 10,689,369 - Lapointe , et al. | 2020-06-23 |
| Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof Grant 10,584,121 - Zhang , et al. | 2020-03-10 |
| SUBSTITUTED INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF App 20190276438 - Lapointe; Blair T. ; et al. | 2019-09-12 |
| Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof Grant 10,344,000 - Lapointe , et al. July 9, 2 | 2019-07-09 |
| HETEROARYL SUBSTITUTED BENZOIC ACIDS AS RORgammaT INHIBITORS AND USES THEREOF App 20190194186 - Zhang; Hongjun ; et al. | 2019-06-27 |
| Substituted indazole compounds as RORgammaT inhibitors and uses thereof Grant 10,287,272 - Lapointe , et al. | 2019-05-14 |
| SUBSTITUTED INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF App 20180312489 - Lapointe; Blair T. ; et al. | 2018-11-01 |
| SUBSTITUTED BICYCLIC PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF App 20180305320 - Lapointe; Blair T. ; et al. | 2018-10-25 |
| Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds Grant 9,867,821 - Bilodeau , et al. January 16, 2 | 2018-01-16 |
| 2,6,7 substituted purines as HDM2 inhibitors Grant 9,682,978 - Christopher , et al. June 20, 2 | 2017-06-20 |
| Substituted pyrrolopyrimidines as HDM2 inhibitors Grant 9,637,493 - Dinsmore , et al. May 2, 2 | 2017-05-02 |
| 2,6,7,8 substituted purines as HDM2 inhibitors Grant 9,540,377 - Cammarano , et al. January 10, 2 | 2017-01-10 |
| Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders Grant 9,309,199 - Wolkenberg , et al. April 12, 2 | 2016-04-12 |
| 2,6,7 Substituted Purines As Hdm2 Inhibitors App 20150368247 - Christopher; Matthew P. ; et al. | 2015-12-24 |
| 2,6,7,8 Substituted Purines As Hdm2 Inhibitors App 20150353553 - Cammarano; Carolyn Michele ; et al. | 2015-12-10 |
| Substituted Pyrrolopyrimidines As Hdm2 Inhibitors App 20150329548 - Dinsmore; Christopher ; et al. | 2015-11-19 |
| Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders Grant 9,024,032 - Wolkenberg , et al. May 5, 2 | 2015-05-05 |
| Substituted imidazopyridines as HDM2 inhibitors Grant 8,962,611 - Christopher , et al. February 24, 2 | 2015-02-24 |
| Substituted Imidazopyridines As Hdm2 Inhibitors App 20140357618 - Christopher; Matthew P. ; et al. | 2014-12-04 |
| Substituted imidazopyridines as HDM2 inhibitors Grant 8,846,657 - Christopher , et al. September 30, 2 | 2014-09-30 |
| Aminopyrimidines as SYK Inhibitors App 20140243290 - Altman; Michael D. ; et al. | 2014-08-28 |
| Substituted Imidazopyridines as HDM2 Inhibitors App 20140179680 - Christopher; Matthew P. ; et al. | 2014-06-26 |
| Aminopyrimidines as SYK inhibitors Grant 8,551,984 - Altman , et al. October 8, 2 | 2013-10-08 |
| Imidazoisoindole neuropeptide S receptor antagonists Grant 8,541,595 - Manley , et al. September 24, 2 | 2013-09-24 |
| Hexahydro-1h-4,7-methanoisoindole-1,3-dione Compounds App 20130178481 - Bilodeau; Mark T ; et al. | 2013-07-11 |
| Inhibitors Of Catechol O-methyl Transferase And Their Use In The Treatment Of Psychotic Disorders App 20130084346 - Wolkenberg; Scott ; et al. | 2013-04-04 |
| Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds Grant 8,410,111 - Bilodeau , et al. April 2, 2 | 2013-04-02 |
| Quinolone neuropeptide S receptor antagonists Grant 8,389,720 - Barrow , et al. March 5, 2 | 2013-03-05 |
| Inhibitors Of Catechol O-methyl Transferase And Their Use In The Treatment Of Psychotic Disorders App 20130005744 - Wolkenberg; Scott ; et al. | 2013-01-03 |
| Isoquinolinone potassium channel inhibitors Grant 8,338,449 - Trotter , et al. December 25, 2 | 2012-12-25 |
| Hexahydro-1h-4,7-methanoisoindole-1,3-dione Compounds App 20120316181 - Bilodeau; Mark T. ; et al. | 2012-12-13 |
| Aminopyrimidines As Syk Inhibitors App 20120277192 - Altman; Michael D. ; et al. | 2012-11-01 |
| Potassium channel inhibitors Grant 8,278,317 - Trotter , et al. October 2, 2 | 2012-10-02 |
| Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds Grant 8,252,799 - Bilodeau , et al. August 28, 2 | 2012-08-28 |
| Potassium channel inhibitors Grant 8,148,535 - Trotter , et al. April 3, 2 | 2012-04-03 |
| Pyridine derivative potassium channel inhibitors Grant 8,080,543 - Trotter , et al. December 20, 2 | 2011-12-20 |
| Aminopyrimidines As Syk Inhibitors App 20110245205 - Altman; Michael D. ; et al. | 2011-10-06 |
| Potassium channel inhibitors Grant 8,030,332 - Trotter , et al. October 4, 2 | 2011-10-04 |
| Imidazoisoindole Neuropeptide S Receptor Antagonists App 20110212941 - Manley; Peter J. ; et al. | 2011-09-01 |
| Quinolone Neuropeptide S Receptor Antagonists App 20110212946 - Barrow; James C. ; et al. | 2011-09-01 |
| Quinazoline potassium channel inhibitors Grant 7,906,521 - Trotter , et al. March 15, 2 | 2011-03-15 |
| Potassium channel inhibitors Grant 7,879,839 - Dinsmore , et al. February 1, 2 | 2011-02-01 |
| Isoquinolinone Potassium Channel Inhibitors App 20100256698 - Trotter; B. Wesley ; et al. | 2010-10-07 |
| Isoquinoline potassium channel inhibitors Grant 7,763,614 - Isaacs , et al. July 27, 2 | 2010-07-27 |
| Isoquinolinone potassium channel inhibitors Grant 7,723,352 - Trotter , et al. May 25, 2 | 2010-05-25 |
| Therapeutic Agents App 20100105697 - Bilodeau; Mark T. ; et al. | 2010-04-29 |
| Decahydroquinoline Analogs As Cb2 Receptor Modulators, Useful In The Treatment Of Pain, Respiratory And Non-respiratory Diseases App 20100099673 - Bilodeau; Mark T. ; et al. | 2010-04-22 |
| Isoquinoline potassium channel inhibitors Grant 7,691,879 - Trotter , et al. April 6, 2 | 2010-04-06 |
| Imidazopyridine Analogs As Cb2 Receptor Modulators, Useful In The Treatment Of Pain, Respiratory And Non-respiratory Diseases App 20090325936 - Bilodeau; Mark T. ; et al. | 2009-12-31 |
| Potassium Channel Inhibitors App 20090233897 - Trotter; B. Wesley ; et al. | 2009-09-17 |
| Potassium channel inhibitors Grant 7,569,589 - Bilodeau , et al. August 4, 2 | 2009-08-04 |
| Potassium Channel Inhibitors App 20090124665 - Trotter; B. Wesley ; et al. | 2009-05-14 |
| Potassium Channel Inhibitors App 20090069312 - Trotter; B. Wesley ; et al. | 2009-03-12 |
| Potassium Channel Inhibitors App 20090069283 - Trotter; B. Wesley ; et al. | 2009-03-12 |
| Tyrosine kinase inhibitors Grant 7,371,754 - Trotter May 13, 2 | 2008-05-13 |
| Potassium Channel Inhibitors App 20080090794 - Dinsmore; Christoph J. ; et al. | 2008-04-17 |
| Tyrosine kinase inhibitors App 20070173525 - Kim; Annette ; et al. | 2007-07-26 |
| Quinazoline potassium channel inhibitors App 20070054894 - Trotter; B. Wesley ; et al. | 2007-03-08 |
| Isoquinoline potassium channel inhibitors App 20070054892 - Isaacs; Richard ; et al. | 2007-03-08 |
| Isoquinolinone potassium channel inhibitors App 20070027177 - Trotter; B. Wesley ; et al. | 2007-02-01 |
| Isoquinoline potassium channel inhibitors App 20060276450 - Trotter; B. Wesley ; et al. | 2006-12-07 |
| Potassium channel inhibitors App 20060030595 - Bilodeau; Mark T. ; et al. | 2006-02-09 |
| Tyrosine kinase inhibitors App 20050239815 - Kim, Annette J ; et al. | 2005-10-27 |
| Tyrosine kinase inhibitors App 20050227988 - Trotter, B. Wesley | 2005-10-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 